
Colgate-Palmolive has been upgraded to a buy rating due to a return in organic sales growth of 2.4% and strong profitability that leads its sector. The company’s 2026 guidance is nearing its long-term targets, supporting optimism for stock multiple expansions. Despite a relatively high forward price-to-earnings ratio of about 22.7 times, Colgate-Palmolive’s superior EBITDA margins, strong free cash flow, and reliable dividends justify its valuation. Risks remain if organic growth fails to exceed 3%, but if targets are met, investors can expect double-digit total returns.